{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T05:07:50Z","timestamp":1774674470416,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:p>Although infection is common in patients with cancer, the distribution of causative agents and the proportion of resistant bacteria in patients with urinary tract infection remain unknown. The aim of this study was to describe the incidence, the causative agents, and the proportion of antimicrobial resistance in bacteria cultured from urine of hospitalized children with cancer. A single-center retrospective chart review of patients with cancer admitted between 2012 and 2020 was performed to identify patients with positive urine culture. Overall, 61 (0.9%) of 7107 patients were identified to have positive urine cultures. Among them, 25 patients (41%) had symptomatic bacteriuria. The most common pathogenic bacterium among all patients was <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic> (<jats:italic toggle=\"yes\">E. coli<\/jats:italic>) (n=15, 25%), followed by <jats:italic toggle=\"yes\">Enterococcus sp.<\/jats:italic> (n=14, 23%), <jats:italic toggle=\"yes\">Klebsiella sp.<\/jats:italic> (n=12, 20%), and <jats:italic toggle=\"yes\">Pseudomonas aeruginosa<\/jats:italic> (<jats:italic toggle=\"yes\">P. aeruginosa<\/jats:italic>) (n=12, 20%). Extended spectrum \u03b2-lactamases\u2013producing <jats:italic toggle=\"yes\">E. coli<\/jats:italic> and Extended spectrum \u03b2-lactamases\u2013producing <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic> were detected in 1 patient (2%) and 4 patients (7%), respectively. No multidrug-resistant <jats:italic toggle=\"yes\">P. aeruginosa<\/jats:italic> and vancomycin-resistant <jats:italic toggle=\"yes\">Enterococcus<\/jats:italic> were detected. The incidence of bacteriuria was found to be low in children with cancer. The distribution of causative agents of bacteriuria in children with solid tumors and hematologic diseases may be different from that in previously healthy children.<\/jats:p>","DOI":"10.1097\/mph.0000000000002524","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T14:06:40Z","timestamp":1660658800000},"page":"21-24","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Incidence and Causative Organisms of Bacteriuria in Children With Cancer: A 9-Year Experience in a Tertiary Pediatric Center"],"prefix":"10.1097","volume":"45","author":[{"given":"Akari","family":"Mitsuboshi","sequence":"first","affiliation":[{"name":"Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5495-8498","authenticated-orcid":false,"given":"Kenji","family":"Kishimoto","sequence":"additional","affiliation":[{"name":"Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Ishida","sequence":"additional","affiliation":[{"name":"Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Kasai","sequence":"additional","affiliation":[{"name":"Infectious Disease Medicine, Kobe Children\u2019s Hospital, Chuo-ku, Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiichiro","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Kosaka","sequence":"additional","affiliation":[{"name":"Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.juro.2013.01.069","article-title":"Antibiotic resistance patterns of outpatient pediatric urinary tract infections","volume":"190","author":"Edlin","year":"2013","journal-title":"J Urol"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1542\/peds.2015-0409","article-title":"Risk factors for recurrent urinary tract infection and renal scarring","volume":"136","author":"Keren","year":"2015","journal-title":"Pediatrics"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.298.2.179","article-title":"Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials","volume":"298","author":"Conway","year":"2007","journal-title":"JAMA"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00467-019-04316-5","article-title":"Multidrug-resistant organisms in urinary tract infections in children","volume":"35","author":"Mahony","year":"2020","journal-title":"Pediatric Nephrology"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1080\/14656566.2017.1383383","article-title":"An update on new antibiotic prophylaxis and treatment for urinary tract infections in chidren","volume":"18","author":"Delbet","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/INF.0000000000002854","article-title":"Resistance to antibiotics of uropathogen bacteria isolated from urine and blood in pediatric cancer patients","volume":"39","author":"Landi","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3109\/08880018.2011.617809","article-title":"Urinary tract infections in pediatric oncology patients with fever and neutropenia","volume":"29","author":"Sandoval","year":"2012","journal-title":"Pediatr Hematol Oncol"},{"key":"R9-20250804","first-page":"309156","article-title":"Prevalence of asymptomatic bacteriuria and antibiotic susceptibility patterns of bacterial isolates among cancer patients and healthy blood donors at the university of Gondar specialized hospital","volume":"2020","author":"Tigabu","year":"2020","journal-title":"Int J Mictobiol"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.ajic.2013.09.002","article-title":"National Healthcare Safety Network (NHSN) report, data summary for 2012, device-associated module","volume":"41","author":"Dudeck","year":"2013","journal-title":"Am J Infect Control"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/08880018.2012.748111","article-title":"Prediction of bacteremia in children with febrile episodes during chemotherapy for acute lymphoblastic leukemia","volume":"30","author":"L\u00fccking","year":"2013","journal-title":"Pediatr Hematol Oncol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10096-014-2247-z","article-title":"Bacteremia in previously healthy children in emergency departments: clinical and microbiological characteristics and outcome","volume":"34","author":"Gomez","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/jamainternmed.2018.4204","article-title":"Effect of increased daily water intake in premenopausal women with recurrent urinary tract infections: a randomized clinical trial","volume":"178","author":"Hooton","year":"2018","journal-title":"JAMA Intern Med"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/37.2.295","article-title":"An 8 year Microbe Base survey of the epidemiology, frequency, and antibiotic susceptibility of Pseudomonas aeruginosa hospital isolates in the United Kingdom","volume":"37","author":"Spencer","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1086\/320185","article-title":"Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999","volume":"32","author":"Low","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jiac.2015.05.014","article-title":"Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases","volume":"21","author":"Kiyohiko","year":"2015","journal-title":"J Infect Chemother"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/499406","article-title":"The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs","volume":"42","author":"Cosgrove","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/jac\/dkm141","article-title":"Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study","volume":"60","author":"Hiller","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1086\/339491","article-title":"Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan","volume":"34","author":"Brown","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/jac\/47.6.781","article-title":"Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case-control study with multivariate analysis for other risk factors","volume":"47","author":"Steinke","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/jac\/dkg146","article-title":"Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections","volume":"51","author":"Metlay","year":"2003","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002524","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:09:03Z","timestamp":1754338143000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002524","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"assertion":[{"value":"2021-11-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}